Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06095401 · ClinicalTrials.gov registry record · NA
Swelling Management After Knee Replacement
A NA study of Arthroplasties, Knee Replacement, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 2
- Study locations
NCT06095401: Recruiting NA study of Arthroplasties, Knee Replacement, sponsored by University of Colorado, Denver.
NCT06095401 is a NA study of Arthroplasties, Knee Replacement that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06095401, a NA study of Arthroplasties, Knee Replacement, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 2
- Study locations
Study Summary
To determine if inelastic adjustable compression garment results in improved surgical limb swelling control (bioimpedance assessment - primary outcome) after TKA compared to control (TED hose).
Conditions Studied
Interventions
- OTHER Inelastic adjustable compression garment (INCOM)
- OTHER Elastic compression garment (CONTROL)
Study Locations (2)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
- Colorado Joint Replacement - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT06095401 shows while recruiting
NCT06095401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Arthroplasties, Knee Replacement appearing as the primary indexed condition, and to 2 interventions - of which Inelastic adjustable compression garment (INCOM) is the first listed.
NCT06095401 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06095401 about?
NCT06095401 is a clinical study titled "Swelling Management After Knee Replacement". To determine if inelastic adjustable compression garment results in improved surgical limb swelling control (bioimpedance assessment - primary outcome) after TKA compared to control (TED hose).
What is the current status of trial NCT06095401?
This trial is currently recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2024-02-21. Estimated completion is 2026-04-30.
What conditions does trial NCT06095401 study?
This clinical trial studies the following conditions: Arthroplasties, Knee Replacement.
What interventions are being tested in trial NCT06095401?
The interventions under investigation include: Inelastic adjustable compression garment (INCOM) (OTHER), Elastic compression garment (CONTROL) (OTHER).
Who is sponsoring clinical trial NCT06095401?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06095401 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasties, Knee Replacement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06095401's enrollment target sits among peer trials
58 1257th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI